Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DVME has begun its bounce back to .0035 (presently .001)
DVME volume is increasing and the PPS share is a stepping up chart formation.
DVME has good revenues, excellent business model, 27 years experience as a company, a fully reporting company, and is significantly undervalued
ytblaaaaaaaaaaaaaaaaaaaaaaaaaaaaa LOL
TMA, me oh my, easy play 1.25 to 2.00, on YGE, grab if weakness tomorrow...this play is huge 6-12 month outlook!
Where were you when YGE was QEE? LOL Good to see you around, Arch. ;)
Peace,
A R C H I E eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee ...your home..
YGE, this is going to be fun again, at 18 and change----also CSUN due for a bounce at 7ish. Good luck traders!
thanks bud---worked TBSI for a sweet 35% gain in a week---now will look to YGE current levels to 30ish....the shippers & solars are bouncing....take the ride!
How are you doing ? Been a long time!
A belated HNY to you !!!!
EZ
Arch, where fort ist though? Don't ask me what language I just spoke but it did sound a bit like Shakespeare.
Peace,
Just a 000 with a fairly low O/S of a confirmed 705 mill, company has PRd there will be no R/S. Green close 3 out of 4 days, the 4th closing on a sell. Looks fairly close to production, with some pretty decent potential. All of this IMO of course, and GLTY.
Interesting. Whats the scoop on this one? iyo...
...first time on this thread. nice one!
Like the cartoon too.
iknowaguy
SBMI gold bottom play, looks ready for a bounce:
DNDN house of pain...next $4 level
why are they still buying it up here. Additional hits on the way based on yesterdays assessment. Shorts are in pig heaven.
mb
still around, visit occasionally, not flippin much now, just select trades, hold for gain, then move on - think NMKT (.44) about to explode...lol
Arch Where are U? U still on Holiday? Hope all is well
Ammobox
yesterday there was stock at .015 and .012, should open and if the offer moves down then they r still there and can be bought up out of the way i believe. just no stock dollar wise in the float. I will sell at .025 i believe. just my opinion.. tqwi
PRVH is up 65% in todays,a profitable penny stock
Hi Arch,jmo but SLJB was good for those in @ .0025-.0050,everyone after that has been chasing,and hopefully trading and not believing,lots of $$ made on SLJB,but not much lately.In fact,looks like more $$ lost than made lately,imo just another pos that made a nice run,and is slowly falling back to the old levels,meanwhile all the SLJB fanatics continue with "investment" talk,lol.Sheesh.
SAOL... chart nice base building......695x.71..
nothing on LFZA, not bad on SLJB
http://www.pinksheets.com/quote/chart.jsp?symbol=SLJB
but OKME, yes, oh yes - in at .15
archangel, comment on LFZA ??? SLJB ???
Did Matt take a round the world cruise ? is this him in the video
CMKX News NASD Charges NevWest Securities Corporation and Principals With Violating Anti-Money Laundering Rules
Tuesday September 26, 10:32 am ET
Firm Failed to File Suspicious Activity Reports Despite Suspicious Sales of Hundreds of Billions of Shares of Sub-Penny Stock by Customer
WASHINGTON, Sept. 26 /PRNewswire/ -- NASD announced today that it has charged NevWest Securities Corporation of Las Vegas and two of its top officers -- President Sergey Rumyantsev and Vice President Antony M. Santos -- with violating NASD's Anti-Money Laundering Rule.
In its complaint, NASD charges that the firm failed to adequately implement and enforce procedures to detect and report suspicious transactions that the firm had reason to suspect involved possible securities fraud. Specifically, the complaint charges that the firm failed to conduct adequate due diligence and file appropriate Suspicious Activity Reports (SARs) in connection with highly suspicious transactions by a customer of the firm. NASD alleges that, during the relevant period, the customer opened 32 accounts at NevWest and sold more than 250 billion shares of a sub-penny stock, which generated total sales proceeds of over $53 million. NASD alleged that NevWest earned commission revenue on the sales totaling $2.5 million -- 36 percent of the firm's total revenues during the relevant period.
"Suspicious Activity Reports provide law enforcement with information that's critical for investigating and prosecuting money laundering, terrorist financing and other financial crimes," said James S. Shorris, NASD Executive Vice President and Head of Enforcement. "Broker-dealers have an obligation to investigate 'red flags' indicating suspicious activity and, where appropriate, to file SARs. Despite a multitude of very obvious red flags, NevWest chose to look the other way, earning millions for itself in the process."
NASD's complaint charges that between January 2003 and May 2005, NevWest, through Rumyantsev and Santos, failed to adequately perform due diligence, file SARs or cease trading in multiple accounts controlled by one of NevWest's customers in connection with more than 500 sale transactions. The transactions involved a sub-penny stock issued by CMKM Diamonds, Inc. (CMKM) that traded in the Pink Sheets until the Securities and Exchange Commission (SEC) revoked the stock's registration in 2005. The complaint further charges that the firm and its officers ignored numerous red flags which reasonably should have caused them to suspect that the customer was violating federal securities laws. The complaint charges that the firm should have filed suspicious activity reports with the U.S. Treasury Department's Financial Crimes Enforcement Network (FinCEN).
Those red flags included:
* The massive volume of CMKM stock that was being sold through NevWest
by this customer, which constituted as much as 36.7% of CMKM's total
outstanding shares;
* Publicly available information about CMKM's financials indicating that
CMKM had almost no assets. CMKM's last quarterly report, filed with
the SEC on Nov. 18, 2002, showed that for the quarter ending September
2002, it had total assets of only $344 cash and total liabilities of
$1,672;
* CMKM's failure to file annual reports with the SEC for the fiscal
years 2002, 2003 and 2004.
* Information showing a relationship between the NevWest customer
engaging in the suspicious transactions and a former officer of CMKM;
* The SEC's temporary suspension of over-the-counter trading in CMKM
securities from March 3, 2005 through March 16, 2005 and the SEC's
action on May 10, 2005 to revoke the registration of each class of
CMKM stock. From March 17, 2005 until May 11, 2005, NevWest continued
to sell at least 22 billion shares for its customer's account.
NASD also alleges that NevWest, through Santos, failed to comply with escrow account requirements and contingency offering terms, in violation of the federal securities laws and NASD rules; failed to timely report customer complaints and disclosure events pursuant to NASD rules, and failed to establish and maintain a supervisory system and procedures that were reasonably designed to detect and prevent these violations.
Under NASD rules, a firm or individual named in a complaint can file a response and request a hearing before an NASD disciplinary panel. Possible remedies include a fine, censure, suspension, or bar from the securities industry, disgorgement of gains associated with the violations, and payment of restitution.
The issuance of a disciplinary complaint represents the initiation of a formal proceeding by NASD in which findings as to the allegations in the complaint have not been made and does not represent a decision as to any of the allegations contained in the complaint. Because this complaint is unadjudicated, interested persons may wish to contact the respondent before drawing any conclusions regarding the allegations in the complaint.
Investors can obtain more information about, and the disciplinary record of, any NASD-registered broker or brokerage firm by using NASD's BrokerCheck. NASD makes BrokerCheck available at no charge to the public. In 2005, members of the public used this service to conduct more than 4.3 million searches for existing brokers or firms and requested more than 194,000 reports in cases where disclosable information existed on a broker or firm. Investors can link directly to BrokerCheck at http://www.nasdbrokercheck.com. Investors can also access this service by calling (800) 289-9999.
NASD is the leading private-sector provider of financial regulatory services, dedicated to investor protection and market integrity through effective and efficient regulation and complementary compliance and technology-based services. NASD touches virtually every aspect of the securities business -- from registering and educating all industry participants, to examining securities firms, enforcing both NASD rules and the federal securities laws, and administering the largest dispute resolution forum for investors and registered firms. For more information, please visit our Web site at http://www.nasd.com.
http://biz.yahoo.com/prnews/060926/dctu024.html?.v=72
Arch,
Good to hear from you. I also try and read more than post but I am finding this market quite interesting. Hope all is going well with you. Get caught up with me via PM when you get a chance.
Peace,
yup....lol....just reading more than posting these days
Are you still alive?
Hey Arch watch SOEN for the next few weeks. I received a mail Friday and they say it's a "1.2 Million Dollar Promotional Budget!" The mailer was 24 pages, well done and sent bulk mail which indicates mailer should be received over the next 3 to 4 weeks by investors.
glty
anny
you be quiet. eom
Hey Arch-take a very good look at RYQG-finance deal is set to be announced. Enjoy the weekend. ;)
thanks ammo, hangin on penny haven for now, my select picks over there for now
Hey Archangel good to see you around again.
WTR & STTK both pretty near bottom......time for for fishing.......and use a big hook:)
HBSC.. news out yeasterday... UNREAL 4th patent... reason to believe MORE news is headed our way... imho...
Press Release Source: Human BioSystems
Human BioSystems to Receive its 4th U.S. Patent: 'Preservation of Blood Platelets with Citrate'
Tuesday May 16, 11:49 am ET
PALO ALTO, CALIFORNIA--(MARKET WIRE)--May 16, 2006 -- On the heels of its earlier announcement regarding the receipt of a third patent (U.S. Patent #7,029,839: "Methods & Solutions for Storing Donor Organs"), Human BioSystems (OTC BB:HBSC.OB - News) announced today that it has been notified by the U.S. Patent Office that it will receive an additional patent titled "Preservation of Blood Platelets with Citrate". This patent grant further adds to the Company's increasing technology base covering a variety of cell preservation methods.
The two major recipient groups for blood platelets are cancer patients that have undergone chemotherapy and/or radiation treatment (about 70%), and trauma patients suffering from extensive bleeding.
"This new patent covers the process of cooling blood platelets to near zero degrees Centigrade to keep them fresh and preserved for greater than the current standard of 5 days. We anticipate being able to extend this process to 7 days and beyond. This will reduce the current need to discard stored platelets that have been preserved by existing methods," explained Dr. David Winter, President of Human BioSystems.
Current technology provides for the storage of platelets at room temperature. This allows any bacteria present to grow rapidly over the current 5-day allowable shelf period.
"By developing a cooling method that prolongs the preservation of platelets, we greatly reduce the risk of bacterial infection while increasing the availability of essential medical resources required to treat cancer and trauma patients," Dr. Winter stated.
Human BioSystems is a developer of preservation platforms for organs and other biomaterials. The Company, which is headquartered in Palo Alto, California with research facilities in Michigan, has made tremendous progress in its nine-year history. This fourth patent is another milestone for Human BioSystems. The Company is also currently conducting tests with two independent and FDA approved laboratories on its proprietary preservation methods.
Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, results from ongoing research and development as well as clinical studies, failure to obtain regulatory approval for the Company's products, if required, failure to develop a product based on the Company's technology, failure of any such products to compete effectively with existing products, the inability to find a strategic partner or to consummate a relationship with a potential strategic partner on acceptable terms, and other factors discussed in filings made by the Company with the Securities and Exchange Commission.
Contact:
Contacts:
Human BioSystems
Harry Masuda
CEO
(650) 323-0943
hmasuda@humanbiosystems.com
A cancer cure at $2 per share?
http://www.investorshub.com/boards/read_msg.asp?message_id=11017443
Could make for a memorable investment....
Caradoc
What do you think of NNSR now after that brief breakout?
NNSR looks like it is going to have a technical breakout this week. Any thoughts?
RYQG-still some time before this one shoots higher. Financing news is just around the corner: http://www.x-treme.ca/company.htm
yep, a phoenix rising there, like SYY as divi play, national campaign rollout coming on, should be good medium range play, appears as nice base right around here/$31
RYQG acting real positive after name change.
USXP looking pretty good today, Arch. :) eom
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |